Hematologist-oncologist and author Vinay Prasad, MD, MPH, dismantles claims that ivermectin and fenbendazole are miracle cancer cures, while also criticizing the FDA’s approval process for expensive anti-cancer drugs…
Jimmy Ruiz, MD, reflects on his career journey in North Carolina and the transformative progress in lung cancer treatment. Early in his career, limited tools like chemotherapy presented…
NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab has “clinically relevant and statistically significant” survival…
NEW YORK (Reuters Health) – Adding hormone therapy to radiotherapy for locally advanced prostate cancer reduces disease recurrence and prolongs survival, according to a report in the August…
Robert Shorr, Ph.D, D.I.C, Chief Executive Officer of Cornerstone Pharmaceuticals, talks about his company’s approach to the treatment of cancer by targeting and exploiting specific metabolic pathways with…
NEW YORK (Reuters Health) – The American Society for Radiation Oncology (ASTRO) has released a consensus statement regarding patient selection and best practices in using accelerated partial breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and the importance of germline vs somatic mutations in predicting prognosis. Summary: Retinoblastoma can be…
NEW YORK (Reuters Health) – Contrary to common opinion, routine cervical screening can identify early-stage adenocarcinoma and adenosquamous carcinoma of the cervix, according to a large case-control study…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas. Summary: Breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
NEW YORK (Reuters Health) – The outcome of treatment for early prostate cancer depends on the patient’s sexual, bowel and urinary function at baseline. These factors also influence…
